Sort
40,608 grants matching “prostate cancer”
UNIV OF WI COMPREHENSIVE CANCER CENTER PARTICIPATING CENTER APPLICATION FOR PROSTATE CANCER RESEARCH PROGRAM CLINICAL CORSORTIUM AWARD
$914,965University Of Wisconsin System · · FY2008 · Department of Defense
COMBINATORIAL INHIBITION OF MYC IN PROSTATE CANCER
$914,900University Of Florida · · FY2019 · Defense Health Agency
Tissue Processing-Sequencing Facility
$914,647Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Biostatistics Resource
$914,492Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2011 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
$914,388Lawrence H Schwartz · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Clinical Fellowship Training Program
$914,335Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2020 · CA
Prostate Section
$914,335Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancer
$914,249Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2024 · CA
Significance of Microenvironment for Prostate Cancer Initiation and Progression
$913,934Stephen R Plymate · University Of Washington · U54 · FY2009 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$913,866Mary Christine Playdon · University Of Utah · U01 · FY2022 · CA
Novel Markers for Disease Outcome in Breast Cancer
$913,469Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$913,077Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Comprehensive proteomic profiling of the ubiquitin pathway in cancer
$912,986Dieter A Wolf · Sanford Burnham Prebys Medical Discovery Institute · RC2 · FY2010 · CA
PLCO Trial Etiologic and Early Marker Study
$912,943Richard S Hayes · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Pain Sensitivity and Unpleasantness in People with Alzheimer's Disease and Cancer
$912,460Ronald L Cowan · University Of Tennessee Health Sci Ctr · R01 · FY2020 · AG
ULTRASMALL PSMA-TARGETED PARTICLE RADIOTHERAPY FOR REGULATING THE IMMUNOSUPPRESSIVE PROSTATE CANCER TUMOR MICROENVIRONMENT AND ENHANCING TREATMENT EFFICACY
$912,321Weill Medical College Of Cornell University · · FY2025 · Defense Health Agency
South Carolina Cancer Disparities Research Center (SC CaDRe)
$912,185Judith Salley · South Carolina State University · U54 · FY2021 · CA
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
$911,971Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
PHARMACOLOGIC INHIBITION OF LIPOGENESIS SUPPRESSES AR AND ITS SPLICE VARIANTS TO INHIBIT PROGRESSION OF CASTRATION-RESISTANT PROSTATE CANCER
$911,798Regents Of The University Of Minnesota · · FY2017 · Department of the Army
Developmental Funds
$911,661Michael A Caligiuri · Ohio State University · P30 · FY2008 · CA
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
$911,328Powel H Brown · University Of Tx Md Anderson Can Ctr · UG1 · FY2022 · CA
NCCU NCMHD RESEARCH CENTER OF EXCELLENCE
$911,229Kevin Sean Kimbro · North Carolina Central University · P20 · FY2010 · MD
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy
$911,048Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2013 · CA
Pathomic Predictors of Prostate Cancer Progression
$910,446Parag Kumar Mallick · Stanford University · R01 · FY2020 · CA
Consultation and Collaboration
$910,442Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA